Suppr超能文献

代谢综合征作为非酒精性脂肪性肝病的预测指标。

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.

作者信息

Hamaguchi Masahide, Kojima Takao, Takeda Noriyuki, Nakagawa Takayuki, Taniguchi Hiroya, Fujii Kota, Omatsu Tatsushi, Nakajima Tomoaki, Sarui Hiroshi, Shimazaki Makoto, Kato Takahiro, Okuda Junichi, Ida Kazunori

机构信息

Department of Gastroenterology, Asahi University, Murakami Memorial Hospital, Gifu, Japan.

出版信息

Ann Intern Med. 2005 Nov 15;143(10):722-8. doi: 10.7326/0003-4819-143-10-200511150-00009.

Abstract

BACKGROUND

The frequent association of nonalcoholic fatty liver disease with components of the metabolic syndrome such as obesity, hyperglycemia, dyslipidemia, and hypertension is well known. However, no prospective study has examined the role of the metabolic syndrome in the development of this disease.

OBJECTIVE

To characterize the longitudinal relationship between the metabolic syndrome and nonalcoholic fatty liver disease.

DESIGN

A prospective observational study.

SETTING

A medical health checkup program in a general hospital.

PARTICIPANTS

4401 apparently healthy Japanese men and women, 21 to 80 years of age, with a mean body mass index (BMI) of 22.6 kg/m2 (SD, 3.0).

MEASUREMENTS

Alcohol intake was assessed by using a questionnaire. Biochemical tests for liver and metabolic function and abdominal ultrasonography were done. Modified criteria of the National Cholesterol Education Program Adult Treatment Panel III were used to characterize the metabolic syndrome.

RESULTS

At baseline, 812 of 4401 (18%) participants had nonalcoholic fatty liver disease. During the mean follow-up period of 414 days (SD, 128), the authors observed 308 new cases (10%) of nonalcoholic fatty liver disease among 3147 participants who were disease-free at baseline and who completed a second examination. Regression of nonalcoholic fatty liver disease was found in 113 (16%) of 704 participants who had the disease at baseline and who completed a second examination. Men and women who met the criteria for the metabolic syndrome at baseline were more likely to develop the disease during follow-up (adjusted odds ratio, 4.00 [95% CI, 2.63 to 6.08] and 11.20 [CI, 4.85 to 25.87], respectively). Nonalcoholic fatty liver disease was less likely to regress in those participants with the metabolic syndrome at baseline.

LIMITATIONS

Ultrasonography may lead to an incorrect diagnosis of nonalcoholic fatty liver disease in 10% to 30% of cases and cannot distinguish steatohepatitis from simple steatosis. Self-reported alcohol intake may cause bias. Because all of the participants were Japanese, generalizability to non-Japanese populations is uncertain.

CONCLUSIONS

The metabolic syndrome is a strong predictor of nonalcoholic fatty liver disease.

摘要

背景

非酒精性脂肪性肝病与代谢综合征的组成成分如肥胖、高血糖、血脂异常和高血压之间的频繁关联已广为人知。然而,尚无前瞻性研究探讨代谢综合征在该疾病发生发展中的作用。

目的

描述代谢综合征与非酒精性脂肪性肝病之间的纵向关系。

设计

一项前瞻性观察性研究。

地点

一家综合医院的健康体检项目。

参与者

4401名年龄在21至80岁之间、身体质量指数(BMI)平均为22.6 kg/m²(标准差为3.0)的表面健康的日本男性和女性。

测量

通过问卷调查评估酒精摄入量。进行肝脏和代谢功能的生化检测以及腹部超声检查。采用美国国家胆固醇教育计划成人治疗小组第三次报告的修订标准来界定代谢综合征。

结果

在基线时,4401名参与者中有812名(18%)患有非酒精性脂肪性肝病。在平均414天(标准差为128)的随访期内,作者在3147名基线时无病且完成第二次检查的参与者中观察到308例新的非酒精性脂肪性肝病病例(10%)。在704名基线时患有该疾病且完成第二次检查的参与者中,发现113名(16%)的非酒精性脂肪性肝病病情有所缓解。基线时符合代谢综合征标准的男性和女性在随访期间更有可能患该疾病(调整后的比值比分别为4.00 [95%可信区间为2.63至6.08]和11.20 [可信区间为4.85至25.87])。基线时患有代谢综合征的参与者,其非酒精性脂肪性肝病病情缓解的可能性较小。

局限性

超声检查在10%至30%的病例中可能导致非酒精性脂肪性肝病的诊断错误,且无法区分脂肪性肝炎和单纯性脂肪肝。自我报告的酒精摄入量可能会导致偏差。由于所有参与者均为日本人,因此对非日本人群的普遍性尚不确定。

结论

代谢综合征是非酒精性脂肪性肝病的一个强有力的预测指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验